Auris Medical Announces Completion of Enrollment in Phase 2 Study for Vertigo Drug, AM-125
Auris Medical Holding Ltd., a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, announced the completion of patient enrollment into Part A of its Phase 2 “TRAVERS” trial with intranasal betahistine in vertigo (AM-125). The company says that it expects to release interim results…
Read More
Non-invasive Nerve Stimulation May Help Provide Relief During Vestibular Migraine Attacks
MINNEAPOLIS, MINNESOTA – A small preliminary study suggests that non-invasive nerve stimulation may hold promise as a treatment for vestibular migraine attacks. A vestibular migraine is a type of migraine that causes vertigo and dizziness with or without headache pain, a condition for which there are currently no approved treatments. The new study was published…
Read More
Researchers Develop New, Highly Accurate, Diagnostic Headset for Dizziness
UK researchers, from the University of East Anglia and Norfolk and Norwich University Hospital, have developed a wearable headset for diagnosing dizziness. A clinical investigation of the Continuous Ambulatory Vestibular Assessment (CAVA) device was recently published in the journal Scientific Reports. After capturing 9000 hours of eye and head movement data from a group of…
Read More
Researchers Regenerate Hair Cells in Vestibular System of Mice
Researchers at the Stanford University School of Medicine have found a way to regenerate hair cells in the inner ears of mice, allowing the animals to recover vestibular function. This is the first time such recovery has been observed in mature mammals. The research was published recently published on July 9 in Cell Reports. According to the…
Read More
Sensorion to Begin Patient Enrollment for Safety Study of Vertigo Drug, Seliforant
MONTPELLIER, FRANCE — Biotech firm Sensorion announced the initiation of patient enrollment in a Phase 2a study (SENS-111-202) to confirm the absence of certain side effects commonly experienced with meclizine (specifically, anticholinergic side effects like sedation and memory loss) during an evoked vestibular imbalance. SENS-111-202 is a randomized, double-blind, double-dummy, placebo-controlled, cross-over trial in patients designed…
Read More
Researchers Discover New Form of Vertigo That Can be Treated
As many audiologists know, vertigo has a myriad of causes and the treatment process can be complex and time-consuming. Researchers in South Korea, however, have identified a new type of vertigo that may be effectively treated with medication. A study, published online last week in the journal Neurology identified what they consider a new condition,…
Read More
New Best Practice Guidelines Issued for BPPV, One of the Most Common Causes of Vertigo
ALEXANDRIA, VIRGINIA — On March 1st, the American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) published an updated clinical practice guideline for healthcare providers on benign paroxysmal positional vertigo (BPPV). The updated guideline, Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo, provides evidence-based recommendations to healthcare providers on diagnosis and treatment of BPPV. Additionally, the…
Read More
Writer Recounts Her Struggles with Superior Canal Dehiscence Syndrome
Superior Canal Dehiscence Syndrome (SCDS) is a balance condition that involves a tear in the uppermost semicircular canal. According to the literature, the condition was first described and defined in 1995 by clinicians at Johns Hopkins School of Medicine. It is believed to occur because the bony surface of the canal did not grow to…
Read More
Fall Risk Increases Above Age 40
Many audiologists who work with patients experiencing equilibrium problems are keenly aware of the relationship between aging and balance. This observation was recently confirmed in a study published online in Frontiers in Neurology. This study, conducted by researchers at Massachusetts Eye and Ear, found vestibular thresholds begin to double every 10 years above the age…
Read More
Sound Pharmaceuticals Hires Two New Executives to Speed Development of Meniere’s Drug
SEATTLE, WASHINGTON — Sound Pharmaceuticals, a Seattle-based biotech firm, announced this week that it has hired two senior executives. Paul Hoskins, appointed to the position of Senior Director of Clinical Operations and G. Michael Wall, appointed to the position of Senior Director of Pharmaceutical Development. The new executives join the company with substantial backgrounds in the pharmaceutical industry. Sound Pharmaceuticals hopes that…
Read More